AAD
  • Registration
  • Daily Coverage
  • Industry Highlights
  • Product Samples
  • Small Exhibit Spotlight
  • Program
Topics
  • Daily Coverage
  • Industry Highlights
  • Product Samples
  • Small Exhibit Spotlight
  • Program
Resources
  • Registration
Facebook iconInstagram iconTwitter icon
Feb 21, 2023

Exciting industry programs return this year in New Orleans!

There are even more opportunities to learn.


Img 7406

Industry Non-CME (INC) Programs are returning for the 2023 AAD Annual Meeting in New Orleans. Be sure to attend these exciting programs on Thursday, March 16, to Monday, March 20, after the scientific sessions. View full program details and preregister here.

Thursday, March 16:
Advancing Therapeutic Conversations
Presented by: AbbVie

A Practical and Comprehensive Assessment of Alopecia Areata in the Clinic
Presented by: Pfizer, Inc.

Moving Beyond Off-Label Management in Prurigo Nodularis: Looking Toward New Treatment Options
Presented by: PeerView Live
Supported by: an independent educational grant from Sanofi and Regeneron Pharmaceuticals

Friday, March 17:
Join Us to Learn More About SOTYKTUTM (deucravacitinib): Clinical Trial Data and Mechanism of Action
Presented by: Bristol Myers Squibb

Prurigo Nodularis and Atopic Dermatitis: Distinct Diseases with Shared and Unique Roles for Type 2 Inflammation
Presented by: Sanofi and Regeneron

Optimal Treatment of Hidradenitis Suppurativa
Presented by: Novartis

Saturday, March 18:
Caring for All Colors: Embracing Diverse Skin Tones to Advance Research and Patient Management
Presented by: Janssen Scientific Affairs, LLC

More Than Skin-Deep Solutions: The Role of Oral JAK Inhibitors in the Treatment of Atopic Dermatitis
Presented by: Answers in CME
This activity is supported by an educational grant from AbbVie.

Starting Emollient Use in the First Days after Birth in Infants at Risk for Atopic Dermatitis: What Does the Latest Research Tell Us?
Presented by: Johnson & Johnson Consumer, Inc.

Sunday, March 19:
Moderate-to-Severe Atopic Dermatitis: A Deeper Look at Systemic Therapies
Presented by: Med Learning Group
This program is supported by an independent medical educational grant from Sanofi and Regeneron Pharmaceuticals.

Exploring Neoadjuvant Immunotherapies for Surgically Resectable Cutaneous Squamous Cell Carcinoma: Targeting Early Intervention to Achieve Best Outcomes
Presented by: Answers in CME
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

The Next Step in GPP Management: Following the IL-36 Pathway in Generalized Pustular Psoriasis (GPP)
Presented by: Boehringer Ingelheim Pharmaceuticals, Inc.

Monday, March 20:
Reframing the Management Approach for Moderate to Severe Atopic Dermatitis
Presented by: Medscape, LLC.
Supported by an independent educational grant from Lilly.

INC Program content is developed and delivered by the sponsor, independent of the official AAD Meeting planned by its Scientific Assembly Committee and does not qualify for continuing medical education (CME) credit.

Visit AAD DermWorld Meeting News Central for more articles.

Interesting Stories
Advancing Therapeutic Conversations
Presented by AbbVie
Advancing Therapeutic Conversations
Residents and Young Physicians: Your Guide to the AAD Annual Meeting
Presented by Neutrogena
Residents and Young Physicians: Your Guide to the AAD Annual Meeting
Janssen-Sponsored Symposium
Presented by Janssen Biotech, Inc.
Janssen-Sponsored Symposium
What makes a biosimilar and an Interchangeable biosimilar different?
Presented by Boehringer Ingelheim
What makes a biosimilar and an Interchangeable biosimilar different?
Prurigo Nodularis and Atopic Dermatitis:
Presented by Sanofi and Regeneron Pharmaceuticals, Inc.
Prurigo Nodularis and Atopic Dermatitis:
Join Us to Learn More About SOTYKTU<sup>TM</sup> (deucravacitinib):
Presented by Bristol Myers Squibb
Join Us to Learn More About SOTYKTUTM (deucravacitinib):
Beyond the Scalp: Deciphering the Complexities of Alopecia Areata...
Presented by Pfizer Inc.
Beyond the Scalp: Deciphering the Complexities of Alopecia Areata...
More in AAD 2023 Annual Meeting
Safi Bahcall
AAD 2023 Annual Meeting
Nurture the unexpected
Mar 20, 2023
Richard L. Gallo, MD, PhD, FAAD
AAD 2023 Annual Meeting
New approach uses microbiome to treat skin disease
Mar 20, 2023
Camp Discovery 92
AAD 2023 Annual Meeting
Refer a patient to Camp Discovery!
Mar 20, 2023
Amy J. McMichael, MD, FAAD
AAD 2023 Annual Meeting
A question of belonging
Mar 20, 2023
David J. Margolis, MD, PhD, FAAD
AAD 2023 Annual Meeting
Dermatologists top the list in antibiotic prescriptions
Mar 20, 2023
22 698 Ia23 Web Card 3x2
AAD 2023 Annual Meeting
Mark your calendar for Innovation Academy 2023
Join the learning
Mar 20, 2023
Getty Images 479036574
AAD 2023 Annual Meeting
Save the date for the 2024 Annual Meeting
Mark you calendar for AM2024
Mar 20, 2023
2022 03 21 12 20 34 6238b40dd1e28
AAD 2023 Annual Meeting
Access your Certificate of Attendance
Download online
Mar 20, 2023
2022 03 21 12 26 25 6238b55bf2d38
AAD 2023 Annual Meeting
Claim CME
Claim CME
Mar 20, 2023
Aad March20
AAD 2023 Annual Meeting
Session highlights for Monday
Mar 20, 2023
Jane Margaret Grant-Kels, MD, FAAD
AAD 2023 Annual Meeting
Ethical dilemmas hiding in plain sight
Mar 20, 2023
John T. Schiller, PhD
AAD 2023 Annual Meeting
Taking on cervical cancer, one shot at a time
Mar 20, 2023
AAD
Facebook iconInstagram iconTwitter icon
© Ascend Media All rights reserved. DermWorld Meeting News Central is a publication of the American Academy of Dermatology.